Alice R. Lim - Concepedia

Author

Alice R. Lim

Also Known As

A R Lim, Alice R. Lim, Alice R. Lim

Publications

556

Citations

H-Index

Concepts

All Affiliations

Alice R. Lim is an author at Infinity Pharmaceuticals (United States) specializing in medicine, oncology, and tumor biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	446
2	Immunology	2	2	302
3	Pharmacology	2	2	302
4	Health Sciences	1	1	52
5	Cell Biology	1	1	52

Alice R. Lim

Publications

556

Citations

H-Index

Page 1

	Year	Citations
PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models David G. Winkler, L. Kerrie, Jonathan P. DiNitto, Chemistry & Biology ImmunologyImmune RegulationImmune SystemImmunotherapyImmune Dysregulation	2013	250
The Hsp90 inhibitor IPI-504 rapidly lowers EML4–ALK levels and induces tumor regression in ALK-driven NSCLC models Emmanuel Normant, Guillermo Paez, Kip A. West, Oncogene OncologyEml4–alk LevelsAlk-driven Nsclc ModelsMedicineHsp90 Inhibitor Ipi-504	2011	144
Cd8− T Cell Transfectants That Express a High Affinity T Cell Receptor Exhibit Enhanced Peptide-Dependent Activation Phillip D. Holler, Alice R. Lim, Bryan K. Cho, The Journal of Experimental Medicine	2001	95
Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer Maurizio Scaltriti, Violeta Serra, Emmanuel Normant, Molecular Cancer Therapeutics Breast OncologyAntitumor ActivityImmunologyCell ProliferationPharmacotherapy	2011	52
The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity<i>in vivo</i> Mark Douglas, Alice R. Lim, James R. Porter, Molecular Cancer Therapeutics	2009	15

Page 1